News

Article

Pharmaceutical Technology

Pharmaceutical Technology-05-01-2003
Volume2003 Supplement
Issue 2

FDA Perspectives: Revising the 1987 Industry Guideline The Development of FDA's Guidance on Aseptic Processing

Author(s):

Richard L. Friedman

The authors describe the solicitation of industry input for the guidance through a process that included a 2002 meeting of the Advisory Committe on Pharmaceutical Science and the subsequent formation of the PQRI Aseptic Processing Working Group.

External Link - article-66623.pdf

Articles in this issue
The PQRI Aseptic Processing Working Group: What was it? What Did It Cover? What Conclusions Did It Reach? Why Was It Important?
FDA Perspectives: Revising the 1987 Industry Guideline The Development of FDA's Guidance on Aseptic Processing
Training for Aseptic Processing Environments

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Related Videos
Benjamin McLeod and Sebastian Lykke Skafte Andersen go behind the headlines to examine the motivations behind recent M&A activity, tariff responses, and more.
Related Content
Blockchain for transparent supply chain tracking | Image Credit: ©Andrey -stock.adobe.com
September 4th 2025

Keys to Navigating the Complex Drug Supply Chain

Susan Haigney
Drug Solutions Podcast: Growth and Advancements in Fill/Finish
September 4th 2025

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
Question mark background | Image Credit: © Leigh-Prather - © Leigh Prather - stock.adobe.com
September 4th 2025

Effectively Using Contamination Control Strategies

Michelle Heiter Susan J. Schniepp
Drug Solutions Podcast: All About Data: Looking at the EHDS in More Detail
September 4th 2025

Drug Solutions Podcast: All About Data: Looking at the EHDS in More Detail

Felicity Thomas
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com
September 4th 2025

Mislabeling Leads to Cyclobenzaprine Hydrochloride Recall

Susan Haigney
New Year, Same Challenges: Pharma’s Ongoing Struggle with FDA 483s
September 4th 2025

New Year, Same Challenges: Pharma’s Ongoing Struggle with FDA 483s

Patrick Falvey Georgia Sloboda Sarah DeDonder Lauren Schoukroun-Barnes
© 2025 MJH Life Sciences

All rights reserved.